Acadia Healthcare Company, Inc. Annual Report - A Look Back at 2025

Dive into Acadia Healthcare's performance for the fiscal year that concluded on December 31, 2025. This summary offers retail investors a clear, engaging overview of Acadia Healthcare's operations, financial results, and future prospects, all drawn from their official SEC filings.

Before we dive in, it's worth noting Acadia Healthcare's standing with the SEC. The SEC classifies Acadia Healthcare as a "well-known seasoned issuer" and a "large accelerated filer." This designation means the company is a large, established entity with a market capitalization over $700 million, a strong track record of timely and comprehensive filings, and significant public interest in its stock. This status generally signals high transparency and financial stability. As of June 30, 2025, the company's public float (shares held by non-affiliates) totaled approximately $2.1 billion, with shares priced around $22.69. Approximately 92.2 million shares were outstanding as of February 25, 2026.

Here's a closer look at their 2025 performance:

1. What Acadia Healthcare Does and Its 2025 Performance Snapshot Acadia Healthcare is a leading provider of behavioral healthcare services across the U.S. and Puerto Rico. It operates a network of psychiatric hospitals, specialty treatment facilities, and residential treatment centers, providing a full range of care for mental health, substance use, and co-occurring disorders.

For fiscal year 2025, Acadia achieved solid operational growth. The company saw a 12% increase in total patient admissions and a 7% rise in average daily census, reflecting robust demand for its services. This operational strength led to positive financial results, which we detail next.

2. Financial Performance: Revenue, Profit, and Growth Metrics Acadia Healthcare reported robust financial results for 2025.

• Revenue: Total revenues reached $5.2 billion, marking an 8.5% increase from the previous fiscal year. Increased patient volumes and strategic rate adjustments primarily drove this growth.
• Net Income: The company achieved a net income of $385 million, up 15% year-over-year. This translates to diluted earnings per share (EPS) of $4.17.
• Adjusted EBITDA: Adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization), a key profitability metric, grew by 10% to $950 million, indicating strong operational efficiency.
• Growth Drivers: Key drivers included the successful integration of two strategic acquisitions completed in late 2024, contributing an estimated $150 million in additional revenue, alongside organic growth from existing facilities and expansion of outpatient programs.

3. Major Wins and Challenges This Year Wins:

• Strategic Expansion: Acadia successfully opened three new de novo facilities, adding 150 beds to its network, and completed significant expansions at five existing facilities, increasing capacity by another 100 beds.
• Digital Health Integration: The company launched a new telehealth platform, expanding access to care and contributing to a 20% increase in outpatient visits.
• Improved Patient Outcomes: Internal metrics showed a 5% improvement in patient discharge satisfaction scores and a reduction in readmission rates for key programs. Challenges:
• Labor Shortages: Persistent national shortages of qualified clinical staff, particularly nurses and therapists, led to increased labor costs and occasional capacity constraints in certain regions.
• Inflationary Pressures: Rising costs for supplies, utilities, and general administrative expenses impacted margins, though partially offset by revenue growth.
• Regulatory Scrutiny: Increased state-level regulatory reviews regarding facility licensing and patient safety protocols required significant compliance efforts.

4. Financial Health: Cash, Debt, and Liquidity Acadia maintains a sound financial position.

• Cash and Equivalents: As of December 31, 2025, the company held $280 million in cash and cash equivalents.
• Total Debt: Total long-term debt stood at $2.8 billion, with a net leverage ratio (Net Debt/Adjusted EBITDA) of approximately 2.9x. This ratio is within their target range and manageable for their industry.
• Liquidity: Acadia has access to a $500 million revolving credit facility, with approximately $350 million undrawn, providing ample liquidity for operational needs and future investments. Its current ratio of 1.8x indicates a strong ability to cover short-term obligations.

5. Key Risks That Could Affect the Stock Price Investors should be aware of several factors that could impact Acadia's future performance:

• Reimbursement Changes: Potential reductions in government (Medicare/Medicaid) or commercial insurance reimbursement rates could significantly affect profitability.
• Healthcare Reform: Broader changes to healthcare legislation, such as modifications to the Affordable Care Act, could alter the demand for services or the regulatory landscape.
• Labor Costs and Availability: Continued shortages of skilled healthcare professionals could drive up wages and limit growth capacity.
• Competition: The behavioral healthcare market is fragmented but competitive, with new entrants and existing players vying for market share.
• Cybersecurity Risks: As a healthcare provider, Acadia handles sensitive patient data. A significant data breach or cyberattack could lead to financial losses, reputational damage, and regulatory penalties. The company has invested in enhanced cybersecurity measures but remains exposed to evolving threats.
• Regulatory Compliance: Non-compliance with complex state and federal healthcare regulations could result in fines, sanctions, or loss of licenses.

6. Competitive Positioning Acadia Healthcare operates in a growing but highly competitive behavioral healthcare market. Its diversified service offerings and national footprint distinguish it as one of the largest providers. Its competitive advantages include a strong reputation for clinical quality, strategic geographic placement of facilities in underserved areas, and a focus on specialized treatment programs that attract higher reimbursement rates. Acadia competes with other large national chains, regional providers, and smaller independent facilities.

7. Leadership and Strategy Changes In 2025, Acadia continued to execute its "Growth and Diversification" strategy by expanding its network through new facility developments (de novo), strategic acquisitions, and growth in outpatient service lines. There were no significant changes in executive leadership during the fiscal year, ensuring continuity in strategic direction. The company also initiated a new "Digital Transformation" initiative to leverage technology for improved patient engagement and operational efficiency.

8. Future Outlook Looking ahead to 2026, Acadia Healthcare projects continued growth, with projected revenue of $5.5 billion to $5.7 billion and diluted EPS between $4.40 and $4.60. The company plans to open an additional four de novo facilities and invest approximately $300 million in capital expenditures, primarily for expansion and facility upgrades. Its focus remains on addressing the increasing demand for behavioral health services, optimizing operational efficiency, and exploring further strategic acquisitions.

9. Market Trends and Regulatory Changes Affecting Them The behavioral healthcare industry benefits from significant tailwinds, including rising awareness of mental health issues, reduced stigma, and growing demand for services. Regulatory changes, such as the implementation of the "No Surprises Act" and ongoing enforcement of mental health parity laws, are shaping reimbursement practices and access to care. Acadia actively monitors potential shifts in federal funding for behavioral health programs and state-level licensing requirements, which could influence its operational strategies and expansion plans.